
Deric Park, MD, discusses a phase 1/2 study of IGV-001, a novel treatment for glioblastoma.

Your AI-Trained Oncology Knowledge Connection!

Deric Park, MD, is a neuro-oncologist at John Theurer Cancer Center, Hackensack University Medical Center, in Hackensack, NJ.